Physician profile
Anna E Slover
NPI 1285213926
$763.72
in general payments reported to CMS, 2019-2025
18 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.18 · 2022: $180 · 2023: $81.22 · 2024: $48.39 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $85.89 | 2021-2022 | |
| Lilly USA, LLC | $83.38 | 2024-2025 | Mounjaro, Zepbound |
| Amgen INC. | $82.03 | 2025 | Evenity |
| Novo Nordisk INC | $76.09 | 2021-2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $70.95 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $58.27 | 2023-2025 | Farxiga |
| Axsome Therapeutics, INC. | $44.94 | 2022-2023 | Auvelity |
| Exact Sciences Corporation | $44.86 | 2025 | The Cologuard Plus Collection Kit |
| Lundbeck LLC | $43.12 | 2023-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $35.60 | 2025 | Uzedy |
| Sanofi-Aventis U.S. LLC | $31.94 | 2022-2025 | |
| Amarin Pharma, INC. | $17.61 | 2021 | |
| Alkermes, INC. | $17.53 | 2025 | Aristada, Lybalvi |
| Pfizer INC. | $16.62 | 2025 | |
| Radius Health, INC. | $16.41 | 2025 | Tymlos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.11 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.07 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Slover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.